Clicky

Sunday, November 1, 2026

Companies

Public company updates

Cynthia L. Hansen acquires deferred stock units at FuelCell

Cynthia L. Hansen, director at FuelCell Energy, acquires 1,419 deferred common stock units, reflecting ongoing compensation strategies in the energy sector.

Saba Capital Management acquires shares in New Germany Fund

Saba Capital Management, L.P. increases its stake in New Germany Fund Inc. with a recent acquisition of 16,577 shares, now holding nearly 3.8 million shares.

Daniel Masters Sells Over 98,000 Shares in CoinShares PLC

Daniel Masters sells over 98,000 shares in CoinShares PLC, signaling potential changes in leadership dynamics within the crypto asset industry.

Livingston III Homer John reports stock transaction at FuelCell

Livingston III Homer John reports a stock transaction related to his director compensation at FuelCell Energy Inc., reflecting industry trends in executive pay.

Drumgoole acquires restricted stock units at Albertsons

Director Christopher Drumgoole acquires 5,423 restricted stock units at Albertsons Companies, signaling confidence in the grocery retail sector.

Boltz acquires 5,423 restricted stock units from Albertsons

William P. Boltz has acquired 5,423 restricted stock units from Albertsons Companies, indicating his commitment to the company and the retail-grocery sector.

Glenbrook Capital Management Boosts Stake in SenesTech, Inc.

Glenbrook Capital Management increases its stake in SenesTech, signaling investor confidence in the agricultural chemicals sector.

Saba Capital Management Acquires Additional Shares in BNY Mellon

Saba Capital Management has increased its stake in BNY Mellon Strategic Municipals, reflecting a strategic move in the investment management sector.

Albertsons director Margaret Ham acquires restricted stock units

Margaret M. Ham, director at Albertsons, acquires 5,423 restricted stock units, reinforcing confidence in the grocery retail sector.

e.l.f. Beauty SVP Franks sells 7,926 shares of common stock

Joshua Allen Franks, SVP of e.l.f. Beauty, sold shares as part of a trading plan, reflecting ongoing market activity in the cosmetics industry.

City Therapeutics reports major stock transactions by director

City Therapeutics, Inc. director John Maraganore acquires over 610,000 shares, signaling confidence in the company's future amid industry developments.

CEO Kevin McCrystle acquires shares in GRANDSTAND Ltd

CEO Kevin McCrystle of GRANDSTAND Ltd has purchased 2,901 shares, signaling confidence in the company's future.

City Therapeutics Reports Major Stock Transactions by Investor

City Therapeutics, Inc. announces significant stock transactions involving Robert Nelsen, highlighting investor confidence in the pharmaceutical sector.

KKR Infrastructure Conglomerate grants stock award to director

KKR Infrastructure Conglomerate LLC has awarded stock to director Joshua A. Mills, reflecting its commitment to executive compensation and performance alignment.

Saba Capital Management Acquires Additional Shares in Fund

Saba Capital Management has acquired 9,969 shares of Ellsworth Growth & Income Fund Ltd, signaling confidence in the fund's future.

City Therapeutics grants stock options to director Greene

City Therapeutics, Inc. grants stock options to director Barry E. Greene, reflecting a strategic move to align interests with shareholders.

Balaji Saranga acquires shares in CDW Corp via stock grant

Balaji Saranga, director at CDW Corp, acquires 504 shares through a restricted stock unit grant, emphasizing leadership incentives in the retail catalog industry.

City Therapeutics sees major stock transactions by ARCH Venture

City Therapeutics, Inc. reports significant stock transactions by ARCH Venture Partners, indicating a shift in ownership stakes in the pharmaceutical sector.

International Seaways CEO Lois K. Zabrocky Sells 2,000 Shares

Lois K. Zabrocky, CEO of International Seaways, sells 2,000 shares of common stock, reflecting ongoing trading activities in the water transportation sector.

Rajasekar Sunil Reports Stock Transactions at HealthEquity

Rajasekar Sunil, Chief Product and Strategy Officer at HealthEquity, Inc., reports multiple stock transactions, reflecting active management of his equity stake.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →